|
|
|
|
| LEADER |
01745nam a2200337 u 4500 |
| 001 |
EB001840031 |
| 003 |
EBX01000000000000001004020 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 050 |
|
4 |
|a RC113.3
|
| 245 |
0 |
0 |
|a Point-of-care tests for infectious diseases
|h Elektronische Ressource
|b a review of clinical and cost-effectiveness and guidelines
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
| 260 |
|
|
|a Ottawa, Ontario, Ottawa, Ontario
|b Canadian Agency for Drugs and Technology in Health, Canadian Electronic Library
|c 2016, 7 March 20162016
|
| 300 |
|
|
|a 1 PDF file (16 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references (pages 8-10)
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Direct-To-Consumer Screening and Testing
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Communicable Diseases / diagnosis
|
| 653 |
|
|
|a Point-of-Care Systems
|
| 653 |
|
|
|a Guidelines as Topic
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report : summary with critical appraisal
|
| 500 |
|
|
|a "07 March 2016". - "CADTH Rapid Response Service."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK355664
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 616.90475
|
| 082 |
0 |
|
|a 380
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This report aims to review the clinical- and cost-effectiveness of over-the-counter POC testing of patient self-test or pharmacist testing for HIV, hepatitis C, influenza, and streptococcal infections. Guidelines associated with the use of POC testing for infectious diseases will also be examined
|